By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid said after the market closed Thursday that it has initiated a recall of all lots of its Xpert MRSA/SA blood culture product because it produces false-negative MRSA (methicillin-resistant Staphylococcus aureus) results, which could potentially contribute to incorrect treatment of an MRSA infection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.